Exagen Inc. announced that On March 20, 2023, James L.L. Tullis informed the Board of Directors (the "Board") of Exagen Inc. that he will resign from the Board effective at the Company's 2023 annual meeting of stockholders. Mr. Tullis' decision to resign was not due to a disagreement with the Board or the Company on any matter relating to the Company's operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.4 USD | +2.19% | -2.10% | -29.65% |
Mar. 18 | Exagen Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 18 | Earnings Flash (XGN) EXAGEN Reports Q4 Revenue $13.8M, vs. Street Est of $11.6M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.65% | 24.13M | |
-11.82% | 87.77B | |
+14.64% | 82.08B | |
+13.31% | 30.03B | |
-10.66% | 17.08B | |
-5.65% | 14.45B | |
+4.48% | 12.37B | |
-31.05% | 11.89B | |
+4.37% | 12.17B | |
+26.50% | 11.62B |
- Stock Market
- Equities
- XGN Stock
- News Exagen Inc.
- Exagen Inc. Announces Board Changes